FDA Approved: GALAFOLD — Supplemental Application (Amicus Therapeutics US, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Galafold (migalastat hydrochloride) from Amicus Therapeutics US, LLC. The action pertains to Fabry disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Drugs mentioned

• GALAFOLD (MIGALASTAT HYDROCHLORIDE)

Snippet

SUPPL AP for GALAFOLD (MIGALASTAT HYDROCHLORIDE)